Niushibao Biotechnology (Shanghai) Co., Ltd – Trademark Portfolio

Entity Type: 99

Niushibao Biotechnology (Shanghai) Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 32 (Light Beverages) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AMBIKO. The owner is based in Jinshan Dist, Shanghai.

No. 589 Xuefu Road, Jinshanwei Town

(Jinshanwei Kechuangyuan)

Jinshan Dist, Shanghai 201512 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AMBIKO
AMBIKO
Registered 2024

Trademark Classifications

Niushibao Biotechnology (Shanghai) Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

32
Light Beverages (1 filing)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

Frequently Asked Questions

How many trademarks does Niushibao Biotechnology (Shanghai) Co., Ltd have?

Niushibao Biotechnology (Shanghai) Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Niushibao Biotechnology (Shanghai) Co., Ltd file in?

Niushibao Biotechnology (Shanghai) Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 32 (Light Beverages). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.

What are Niushibao Biotechnology (Shanghai) Co., Ltd's most well-known trademarks?

Niushibao Biotechnology (Shanghai) Co., Ltd's registered trademark portfolio includes well-known marks such as AMBIKO. These are among 1 currently registered trademark in the portfolio.

What is Niushibao Biotechnology (Shanghai) Co., Ltd's trademark registration success rate?

Niushibao Biotechnology (Shanghai) Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.